Alkermes Plc (ALKS)
47.74
+0.54
(+1.14%)
USD |
NASDAQ |
Sep 02, 16:00
47.70
-0.04
(-0.08%)
After-Hours: 17:53
Alkermes Cash and Short Term Investments (Quarterly) : 656.58M for June 30, 2026
Cash and Short Term Investments (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash and Short Term Investments (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 656.58M |
| March 31, 2026 | 511.86M |
| December 31, 2025 | 1.319B |
| September 30, 2025 | 1.111B |
| June 30, 2025 | 1.016B |
| March 31, 2025 | 884.02M |
| December 31, 2024 | 751.67M |
| September 30, 2024 | 908.86M |
| June 30, 2024 | 876.12M |
| March 31, 2024 | 745.05M |
| December 31, 2023 | 773.49M |
| September 30, 2023 | 889.15M |
| June 30, 2023 | 829.05M |
| March 31, 2023 | 600.46M |
| December 31, 2022 | 608.46M |
| September 30, 2022 | 580.18M |
| June 30, 2022 | 580.97M |
| March 31, 2022 | 528.87M |
| December 31, 2021 | 536.31M |
| September 30, 2021 | 560.30M |
| June 30, 2021 | 538.34M |
| March 31, 2021 | 541.00M |
| December 31, 2020 | 635.03M |
| September 30, 2020 | 569.38M |
| June 30, 2020 | 532.56M |
| Date | Value |
|---|---|
| March 31, 2020 | 495.99M |
| December 31, 2019 | 534.98M |
| September 30, 2019 | 587.18M |
| June 30, 2019 | 570.29M |
| March 31, 2019 | 582.13M |
| December 31, 2018 | 539.30M |
| September 30, 2018 | 467.09M |
| June 30, 2018 | 433.51M |
| March 31, 2018 | 404.56M |
| December 31, 2017 | 433.50M |
| September 30, 2017 | 450.10M |
| June 30, 2017 | 475.11M |
| March 31, 2017 | 476.42M |
| December 31, 2016 | 497.23M |
| September 30, 2016 | 549.46M |
| June 30, 2016 | 655.98M |
| March 31, 2016 | 625.39M |
| December 31, 2015 | 534.78M |
| September 30, 2015 | 771.76M |
| June 30, 2015 | 776.77M |
| March 31, 2015 | 747.46M |
| December 31, 2014 | 631.17M |
| September 30, 2014 | 572.57M |
| June 30, 2014 | 638.49M |
| March 31, 2014 | 552.27M |
Cash and Short Term Investments Definition
Represents the sum of cash and short term investments.
Cash and Short Term Investments (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash and Short Term Investments (Quarterly) Benchmarks
| Amarin Corp. Plc | 314.85M |
| Jazz Pharmaceuticals Plc | 2.200B |
| Prothena Corp. Plc | 288.19M |
| ACADIA Pharmaceuticals, Inc. | 956.47M |
| Biogen, Inc. | 1.285B |